chrisvoncsefalvay/vaers-outcomes huggingface dataset:
spasms; her arms "tightens up" during the night; having trouble sleeping/she barely sleeps 3-4 hours per night; muscle in her arm tightens up so tight it wakes her; both arms hurt from her elbows to shoulders and it is terrible at night.; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 78-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, #lot: ER8737, expiration date: 31Jul2021) via an unspecified route of administration administered in Arm Left on 03Apr2021 (at the age of 78-years-old) as single dose for COVID-19 immunization. Medical history included ongoing breast cancer diagnosed 2.5 years ago and still being followed for it, ongoing irritable bowel syndrome diagnosed 5-6 years ago and had muscle aches in her legs from cholesterol medicines in the past. Concomitant medications included acetylsalicylic acid (ASPRIN, strength: 81 mg) at 81 mg once daily, bumetanide (strength: 1 mg) at 1 mg tables, 2 tablets on Monday, Wednesday and Friday and one tablet the rest of the week, glucosamine, methylsulfonylmethane (GLUCOSAMINE & MSM) one in the morning and one at night, 2x/day), letrozole (strength: 2.5 mg) at 2.5 mg once daily, levothyroxine (strength: 25 mg) at 25 mg, alternate day, lisinopril (strength: 5 mg) at 5 mg one at night, loratadine (CLARITINE), lorazepam, omeprazole (strength: 20 mg) at 20 mg, alternate day, probiotics once daily, calcium (strength: 600 mg) at 600 mg twice daily, vitamin c (ASCORBIC ACID, strength: 500 mg) at 500 mg once daily, vitamin d3 (strength: 500 mg) at 500 mg once daily, simethicone (strength: 125 mg) at 125 mg once daily. It was reported that within 2 days after vaccination, on 05Apr2021, the patient right arm started hurting from elbow to shoulder along with left arm then started hurting also but doesn't recall at what point it started. Patient thought that pain was due to the vaccine since in her left arm was also in pain. Further patient described pain as excruciating at night, in the evenings or when lays down, and tolerable during the day. On an unspecified date, the patient specified about the spasms and arms that tightens up during the night, which keep her up. On an unspecified date, the patient added she barely sleeps 3-4 hours per night, despite the muscle relaxant she takes. Patient further explained she cannot lift her arms as high in the morning and provided the following example: she couldn't open her venetian blind or put her coat without help. She specified the pain eases up during the day and can't move her arms as it hurts, the pain on a scale of 1-10 was a 15. Reporter assessed the event as non-serious. On unspecified date the patient underwent lab tests and procedures which included left arm x-ray and left arm x-ray found to be negative. The outcome of the events both arms hurt from her elbows to shoulders and it is terrible at night was not recovered while the outcome of the rest of events was unknown.  Follow up attempts needed. Further information is expected.
Information has been received from a physician concerning a 24 year old female with no pertinent medical history and no history of drug reactions/allergies who on 26-JAN-2007 was vaccinated with Gardasil vaccine (yeast) (lot# not reported), IM. There was no concomitant medication. On 26-JAN-2007, the patient developed a sore throat, fever, and chills later that evening. She went to the emergency room on 30-JAN-2007 where she exhibited expressive aphasia. A computed tomography (CT) scan showed nothing. She was admitted to the hospital where she a neurology consult. All tests have come up negative (CT scan, magnetic resonance imaging, complete blood count, electrolytes, and C-reactive protein). The physician stated that the patient has 3 chinchilla pets and one of them has a fungal infection which is currently being treated with myconazole spray. The physician consulted the veterinarian as well as an infectious disease specialist. The physician saw the patient today and she was able to form some sentences. The physician is observing the patient and will order some additional tests. The physician reported the event will be a disability if this adverse event continues. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapy were not reported. On 21-SEP-2016, the patient was inadvertently vaccinated with an expired dose PNEUMOVAX 23 (lot # K010466, expiration date 23-MAR-2016, intramuscularly, dose not reported). No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Extreme Fatigue, brain fog, nausea, headache, body aches for 5 days
Pt developed localized rash on right side of face about 1 hour after vaccine administration. Rash is not pruritic and not painful. No other symptoms present
needle of syringe was not attached securely from package.  When administering the vaccine .. most came out of the hub and was not administered into the patient.  I readministered the vaccine as patient did not receive any dose
c//o Heart racing.  B/P 172/102; Pt instructed to continue to self monitor and if symptoms worsen or new symptoms develop seek emergency attention.  Pt instructed to seek medical advise for second dose.  If second dose recommended patient may not use the Drive thru locations and must get vaccination at doctor's office for more controlled environment.
103 temp, chills, very sick, thought I was dying, went for strep throat check.
Rash that is warm to touch appeared on day 2. Soreness every day, even on day 6 after shot given
A report has been received from a Health Professional concerning a 2 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 05-Dec-2013. The nurse reported that patient had gotten some FLUMIST in their eye which started on 05-Dec-2013. The outcome of the event of administration into eye is unknown. The report was considered to be non-serious.
I had restylane dermal filler injected in my facial tear troughs on 3/23/21 and was told to expect bruising, swelling, and tenderness for a few days/up to a week. It?s now 4/4/21 and I still have fairly significant bruising, swelling, and inflamed nodules at the injection site under my eyes.
Evening of the same day of the vaccine administration- began itching and hives all over body. Took over the counter Benadryl PO X2 doses over the next 12 hours and in the morning symptoms were gone. Never had a vaccine reaction prior and receives the flu vaccine annually.
I received all 3 Moderna vaccinations: 1 = lot 016b21a - 4/1/2021 2 = lot 002c21a - 4/29/2021 3 = as listed above (lot number handwriting is hard to read) My normal mensuration cycles run 19 days between end day to start day. After my 3rd vaccination, I had an early menstruation period, starting 14 days after the end date of the last one. AS of my most recent menstruation, my cycle seems to be back to the normal number of days.
Itchy rash on chest, neck, arms. Blotchy red skin.  Advised diphenhydramine, which patient took. At 8:45 AM the next day, all symptoms had resolved.
Engerix-B 1ml given to a 19-year-old; Engerix-B 1ml given to a 19-year-old; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 19-year-old patient who received HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received Engerix B 1 ml. On an unknown date, an unknown time after receiving Engerix B, the patient experienced inappropriate age at vaccine administration (Verbatim: Engerix-B 1ml given to a 19-year-old) and overdose (Verbatim: Engerix-B 1ml given to a 19-year-old). The outcome of the inappropriate age at vaccine administration and overdose were unknown.   Additional Information: GSK Receipt Date:15-MAR-2023  The pharmacist called to report the administration of Engerix-B (1ml dose) to a 19 year-old patient.  The reporter asked if there was information about how to proceed with the such patient.  The reporter did not provide patient identifiers nor information about the Engerix-B dose administered (lot number/expiry date/date of administration). The follow-up could not be possible as no contact details were available. The patient received Engerix-B above than the recommended age limit, which led to inappropriate age at vaccine administration. The patient received Engerix-B more than the recommended dose which led to overdose.
Shingles; Headache; This is a spontaneous report from a contactable consumer. An 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6201), intramuscular, administered in Arm Left on 11Feb2021 09:30 as single dose for covid-19 immunization (Age at vaccination: 85 years). Medical history included blood pressure problems and gout. The patient's concomitant medications were not reported.  The patient stated that she had the first shot on 11Feb2021, then the night of the 14th, she had this terrible headache (14Feb2021) and the next day, she still had it. Her doctor couldn't see her at this point. Finally, about Feb 16th, she went to hospital and she was told it was shingles (16Feb2021). She was given treatment for the shingles and it gradually has gotten much better. Outcome of the event shingle was recovering while outcome of the remaining event was unknown.
blood in urine before & after dinner;later coughing, chronic nose bleed & sore throat;pt still coughing;
This report has been received from the nurse reported that VARIVAX (merck) (lot# H020587, expiration date 13-NOV-2014) and PROQUAD (MARRS# 1311USA012185) were trough unsupported temperature excursions on 26-JUN-2013, 01-JUL-2013, 22-JUL-2013 thru 31-JUL-2013 and the entire month of August 2013. On 22-AUG-2013 the patient was administered the unsupported VARIVAX (merck) (dose and route not reported). This is one of several reports received from the same source (MARRS# 1311USA002616, 1312USA003306, 1312USA003307, 1312USA003309, 1312USA003310, 1312USA003311, 1312USA003312, 1312USA003313, 1312USA003314, 1312USA003315, 1312USA003316, 1312ISA003317). Additional information is not expected.
Pain in the arm; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-May-2021 and was forwarded to Moderna on 03-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039821A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.  Treatment information was not reported.
Left upper arm in agonizing, excruciating, throbbing pain..; Left upper arm in agonizing, excruciating, throbbing pain; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included polymyalgia rheumatica, rheumatoid arthritis, osteoporosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included levothyroxine sodium (TIROSINT) from an unknown date for an unspecified indication. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. On 27Mar2021 at 05:00, the patient woke at 05:00 the next morning of receiving vaccine, and experienced left upper arm in agonizing, excruciating, throbbing pain, lasted several hours. Pain got better, but did not leave, now 26 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left upper arm in agonizing, excruciating, throbbing pain, lasted several hours was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Decreased ability to ambulate using left leg. Left thigh painful, warm, pink, swollen, extending to knee.
Chills and weakness, no fever. Severe diarrhea now over 12 hours
This case was reported by a consumer and described the occurrence of injection site erythema in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema was unknown and the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site erythema and injection site pain to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The reporter asked whether pain and redness at the injection site were common side effects. The patient's arm was sore till the time of reporting. The reporter asked how long should this last.
1 to 2 days after administration, pt had large, red welt at injection site that was hot to the touch. Also had fever, headache, earache on left side andnumb pinky and ring fingers left side.
Presents to ED after her second COVID-19 vaccination on 4/13/2021. Immediately thereafter she had fever, body aches, headaches, and her feet felt tight. The symptoms gradually declined. On 4/19/2021 she developed stocking glove numbness that began to ascend up her legs. Her calf's feel like they are being squeezed. She has paresthesia's currently, she describes them as prickly and needlelike. Labs, urinalysis, CBC, and chemistries unremarkable, troponin negative. Probable AIDP given history and examination. IVIG and steroids given. Guillain Barre syndrome suspected. MRI brain and cervical spine performed to eval for CNS pathology. MRI brain: No acute intracranial formalities. No evidence of mass or infarct. However noted to several bilateral Supratentorial T2/FLAIR hyperintense foci mostly in the centrum semi vale and optic radiations. These are nonspecific foci and should be correlated for demyelinating disease, small vessel disease, traumatic brain injury, Lyme disease, chronic migraine etiologies. MRI cervical spine was unremarkable. Patient DC'ed in stable condition and told to F/U with neurology clinic.
THURSDAY EVENING I FELT COLD AND CHILLS, BONES AND JOINTS ACHE, SOME HEADACHE. FRIDAY, STILL FELT VERY SICK AND COLDER, FELT WEAK, ARM HURTING, JOINTS MORE PAINFUL, I FELT LIKE MY HEAD WAS GOING TO BLOW UP THE WORST HEADACHE IN MY LIFE.  FELT PAIN IN BACK AND FRONT WHERE MY KIDNEYS ARE. FEVER OF 103 AND CHANGED CLOTHES OFTEN BECAUSE I WAS ALL WET.  RIGHT ARM WAS SO PAINFUL NO ONE COULD TOUCH IT. RED AND HARD AND SWOLLEN.  NO APPETITE.  TREATMENT FROM FACILITY HOT PACKS ON ARM, TAKE CLARITIN FOR TWO WEEKS, TAKE TYLENOL OR IBUPROFEN AS NEEDED. HAVE FU APPT.
Tongue felt swollen and dizzy after vaccine. Evaluated by EMS. Pulse ox 99% BP 100/62  To stay extra 15 minutes. Benadryl and ER prn. Client felt better and went home.
I was coughing all the time and couldn?t control. It felt like I was having an asthma attack but stronger. I went to the ER. I was diagnosed with bronchitis. The doctor prescribed me Prednisone 20 mg which helped. I tested for COVID-19, and it was negative.
RED, HARDENED SKIN NOTED ON RIGHT DELTOID AREA, PT STATES THAT THIS WAS RESULT OF VACCINE GIVEN.
Migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.   Reporter did not allow further contact
Looked like a cellulitis. Rash, erythema multiforme and urticaria pruritus. Cephalexin 500 mg QID, etodolac 400 mg BID.
I received a flu vaccine at my local pharmacy. It was the recommended double dose as I am 65 years old. The next day I had a 99.4 degree fever, muscle aches, and cough. I have never previously had a reaction to a flu shot. A nap in the middle of the day made it better. The following day I'm feeling fine.
Near syncopal episode following administration of GARDASIL 9 and MENACTRA. BP prior to vaccine 108/69. Following vaccine BP 88/60. Other vitals WNL. Pt assisted to exam room, recumbent for 15 mins, symptoms resolved spontaneously. Pt experienced near syncopal event in July 2017 following blood draw, unrelated to vaccine administration.
pt recv vax 15JUL97 & pt noticed redness beyond bandaid on 17JUL97 PM, then less pain;aunt accompanied pt to clinic where 5cm in diameter & erythema (blanching) were noted;temp nl 98.4;
Vertigo with head motion lasting 10 seconds but has persisted for at least 30 days.
Dose drawn up on 10/12/22 but not given. Reordered on 10/18/22 but old expired dose accidentally given instead of new dose.
Booster induced sore arm the next day. "I" woke up and felt some soreness go down "my" whole arm, like nerve pain but it was not extremely painful.; Armpit it also sore and tender to touch.; Also feeling a little warm; Feel kind of sick; "I" also feel tired; "I" have mucus buildup in "my" throat; Booster dose; This is a spontaneous report from a contactable other healthcare professional, the patient. A 24-year-old non-pregnant female patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an intramuscular route of administration in the left arm on 28Oct2021 at 10:45(at the age of 24-years-old) as a single dose for COVID-19 immunisation. The medical history included polycystic ovarian syndrome (PCOS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included metformin (MANUFACTURER UNKNOWN) before booster shot from an unknown date for an unknown indication and unspecified birth control throughout all shots from an unknown date and all were unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration on 25Jan2021 (at the age of 23-years-old) and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration on 15Feb2021 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. The patient also took previously amoxicillin(MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. On 29Oct2021, the next day, the patient experienced booster induced sore arm and woke up and felt some soreness went down whole arm, like nerve pain but it was not extremely painful. The armpit also sore and tender to touch. The patient also felt a little warm, felt kind of sick, felt tired and she noticed she had mucus buildup in her throat. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events booster induced sore arm the next day and woke up and felt some soreness went down whole arm, like nerve pain but it was not extremely painful, armpit also sore and tender to touch, also felt a little warm, felt kind of sick, felt tired, mucus buildup in throat were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a nurse practitioner via company representative refers to an unknown age female patient. The patient had no past medical history. On 13-AUG-2013 the patient had a syncopal episode immediately after receiving her 3rd dose of GARDASIL (lot# H020002, expiration date: 08-AUG-2015), intramuscularly at unspecified location. The patient was sitting down as indicated and this episode occurred as the needle was being removed from the injection site. The patient was physically supported until symptoms resolved which was approximately 15 seconds. The patient was sitting on the exam room table with her feet 'dangling' when this occurred. No concomitant therapies reported. The patient had sought medical attention. No lab studies were performed. On 13-AUG-2013, the patient recovered from syncopal episode. Additional information has been requested.
No additional adverse event reported, no further information provided; the patient was vaccinated expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II); This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported.   On 02-FEB-2021, the patient was vaccinated expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (Lot# T003385 and expiration date 28-JAN-2022) (frequency were not reported) as prophylaxis. (Expired product administered). The vaccine not have any temperature excursion. No additional adverse event reported, no further information provided.
Lacke of appetite 20AUG91 AM; late nite of 20AGU91 fever, afternoon 22AUG91 fever, vomiting; to MD 23AUG91 t104 given meds; 25AUG91 rash beginning stomach area x 2 days;